Dewei He
About
Dewei He is a scholar working on Neurology, Neurology and Molecular Biology.
According to data from OpenAlex, Dewei He has authored 26 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Neurology, 9 papers in Neurology and 8 papers in Molecular Biology. Recurrent topics in Dewei He's work include Neuroinflammation and Neurodegeneration Mechanisms (18 papers), Parkinson's Disease Mechanisms and Treatments (9 papers) and Neurological Disease Mechanisms and Treatments (4 papers). Dewei He is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (18 papers), Parkinson's Disease Mechanisms and Treatments (9 papers) and Neurological Disease Mechanisms and Treatments (4 papers). Dewei He collaborates with scholars based in China, South Korea and Switzerland. Dewei He's co-authors include Bingxu Huang, Xin Ran, Juxiong Liu, Guangxin Chen, Wei Wang, Shoupeng Fu, Yuhang Li, Shoupeng Fu, Bai Li and Dianfeng Liu and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, Free Radical Biology and Medicine and International Journal of Molecular Sciences.
In The Last Decade
Dewei He
26 papers receiving 1.1k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Dewei He China | 16 | 571 | 222 | 153 | 137 | 125 | 26 | 1.1k | ||
| Xin Ran China | 17 | 664 1.2× | 190 0.9× | 177 1.2× | 142 1.0× | 148 1.2× | 27 | 1.3k | ||
| Rui Zhao China | 26 | 762 1.3× | 138 0.6× | 144 0.9× | 153 1.1× | 185 1.5× | 99 | 1.9k | ||
| Shoupeng Fu China | 15 | 744 1.3× | 215 1.0× | 412 2.7× | 185 1.4× | 196 1.6× | 25 | 1.6k | ||
| Shoupeng Fu China | 29 | 874 1.5× | 296 1.3× | 191 1.2× | 148 1.1× | 225 1.8× | 94 | 2.0k | ||
| Jungkee Kwon South Korea | 26 | 852 1.5× | 109 0.5× | 126 0.8× | 202 1.5× | 109 0.9× | 84 | 1.8k | ||
| Shaoping Wu United States | 15 | 693 1.2× | 173 0.8× | 206 1.3× | 165 1.2× | 75 0.6× | 24 | 1.4k | ||
| Tianlong Liu China | 23 | 502 0.9× | 168 0.8× | 74 0.5× | 45 0.3× | 94 0.8× | 66 | 1.2k | ||
| Su-Min Lim South Korea | 20 | 758 1.3× | 79 0.4× | 273 1.8× | 97 0.7× | 117 0.9× | 47 | 1.3k | ||
| Qamre Alam Saudi Arabia | 18 | 426 0.7× | 129 0.6× | 177 1.2× | 111 0.8× | 73 0.6× | 51 | 1.0k | ||
| Songwei Yang China | 18 | 683 1.2× | 136 0.6× | 132 0.9× | 58 0.4× | 143 1.1× | 42 | 1.4k |
Countries citing papers authored by Dewei He
Since
Specialization
Citations
This map shows the geographic impact of Dewei He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dewei He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dewei He more than expected).
Fields of papers citing papers by Dewei He
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Dewei He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dewei He. The network helps show where Dewei He may publish in the future.
Co-authorship network of co-authors of Dewei He
This figure shows the co-authorship network connecting the top 25 collaborators of Dewei He. A scholar is included among the top collaborators of Dewei He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dewei He. Dewei He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Gao, Xiyu, Shoupeng Fu, Yichen Liu, et al.. (2025). TRPM8 activation inhibits neuroinflammation and ameliorates neurodegeneration by modulating Nrf2/HO-1 and NF-κB pathways in vivo and in vitro. Free Radical Biology and Medicine. 235. 248–260.
2.
Xu, Dianwen, Ji Cheng, Dewei He, et al.. (2024). Amygdalin Alleviates DSS-Induced Colitis by Restricting Cell Death and Inflammatory Response, Maintaining the Intestinal Barrier, and Modulating Intestinal Flora. Cells. 13(5). 444–444.
3.
Liu, Dianfeng, et al.. (2024). Allantoin ameliorates dopaminergic neuronal damage in MPTP-induced Parkinson's disease mice via regulating oxidative damage, inflammation, and gut microbiota disorder. Food & Function. 15(18). 9390–9408.
4.
He, Dewei, Xiyu Gao, Shuo Yang, et al.. (2024). Orally administered neohesperidin attenuates MPTP-induced neurodegeneration by inhibiting inflammatory responses and regulating intestinal flora in mice. Food & Function. 15(3). 1460–1475.
5.
Xu, Dianwen, et al.. (2024). Hordenine Alleviates Lipopolysaccharide-Induced Mastitis by Suppressing Inflammation and Oxidative Stress, Modulating Intestinal Microbiota, and Preserving the Blood–Milk Barrier. Journal of Agricultural and Food Chemistry. 72(39). 21503–21519.
6.
Wang, Hefei, Dewei He, Zhe Li, et al.. (2023). Oral administration of sophoricoside (SOP) inhibits neuronal damage and neuroinflammation to curb neurodegeneration in Parkinson's disease. Chemico-Biological Interactions. 384. 110726–110726.
7.
Huang, Bingxu, Guiqiu Hu, Shuo Yang, et al.. (2023). α-Cyperone protects dopaminergic neurons and inhibits neuroinflammation in LPS-induced Parkinson’s disease rat model via activating Nrf2/HO-1 and suppressing NF-κB signaling pathway. International Immunopharmacology. 115. 109698–109698.
8.
Gao, Xiyu, Dewei He, Yanting Liu, et al.. (2023). Oral administration of Limonin (LM) exerts neuroprotective effects by inhibiting neuron autophagy and microglial activation in 6-OHDA-injected rats. International Immunopharmacology. 123. 110739–110739.
9.
He, Dewei, Shoupeng Fu, Hefei Wang, et al.. (2023). Activation of HCA2 regulates microglial responses to alleviate neurodegeneration in LPS-induced in vivo and in vitro models. Journal of Neuroinflammation. 20(1). 86–86.
10.
He, Dewei, Shuo Yang, Xiyu Gao, et al.. (2023). Notopterol inhibits LPS-induced inflammation in BV-2 cells via AKT/Nrf2/HO-1 signaling axis. International Immunopharmacology. 120. 110334–110334.
11.
He, Dewei, Guiqiu Hu, Ang Zhou, et al.. (2022). Echinocystic Acid Inhibits Inflammation and Exerts Neuroprotective Effects in MPTP-Induced Parkinson’s Disease Model Mice. Frontiers in Pharmacology. 12. 787771–787771.
12.
He, Dewei, Shoupeng Fu, Ang Zhou, et al.. (2021). Camptothecin Regulates Microglia Polarization and Exerts Neuroprotective Effects via Activating AKT/Nrf2/HO-1 and Inhibiting NF-κB Pathways In Vivo and In Vitro. Frontiers in Immunology. 12. 619761–619761.
13.
Gao, Xiyu, Dewei He, Dianfeng Liu, et al.. (2020). Beta-naphthoflavone inhibits LPS-induced inflammation in BV-2 cells via AKT/Nrf-2/HO-1-NF-κB signaling axis. Immunobiology. 225(4). 151965–151965.
14.
Meng, Tianyu, Shoupeng Fu, Dewei He, et al.. (2020). Evodiamine Inhibits Lipopolysaccharide (LPS)-Induced Inflammation in BV-2 Cells via Regulating AKT/Nrf2-HO-1/NF-κB Signaling Axis. Cellular and Molecular Neurobiology. 41(1). 115–127.
15.
Huang, Bingxu, Juxiong Liu, Shoupeng Fu, et al.. (2020). α-Cyperone Attenuates H2O2-Induced Oxidative Stress and Apoptosis in SH-SY5Y Cells via Activation of Nrf2. Frontiers in Pharmacology. 11. 281–281.
16.
Du, Jian, Dianfeng Liu, Ang Zhou, et al.. (2020). Menthol protects dopaminergic neurons against inflammation-mediated damage in lipopolysaccharide (LPS)-Evoked model of Parkinson’s disease. International Immunopharmacology. 85. 106679–106679.
17.
Liu, Bingrun, Bingxu Huang, Guiqiu Hu, et al.. (2019). Isovitexin-Mediated Regulation of Microglial Polarization in Lipopolysaccharide-Induced Neuroinflammation via Activation of the CaMKKβ/AMPK-PGC-1α Signaling Axis. Frontiers in Immunology. 10. 2650–2650.
18.
Li, Yuhang, Yalong Zeng, Tianyu Meng, et al.. (2019). Farrerol protects dopaminergic neurons in a rat model of lipopolysaccharide-induced Parkinson's disease by suppressing the activation of the AKT and NF-κB signaling pathways. International Immunopharmacology. 75. 105739–105739.
19.
Chen, Guangxin, Xin Ran, Bai Li, et al.. (2018). Sodium Butyrate Inhibits Inflammation and Maintains Epithelium Barrier Integrity in a TNBS-induced Inflammatory Bowel Disease Mice Model. EBioMedicine. 30. 317–325.
20.
Chen, Guangxin, Bingxu Huang, Shoupeng Fu, et al.. (2018). G Protein-Coupled Receptor 109A and Host Microbiota Modulate Intestinal Epithelial Integrity During Sepsis. Frontiers in Immunology. 9. 2079–2079.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Xin Ran Breakdown of academic impact, for papers by Rui Zhao Breakdown of academic impact, for papers by Shoupeng Fu Breakdown of academic impact, for papers by Shoupeng Fu Breakdown of academic impact, for papers by Jungkee Kwon Breakdown of academic impact, for papers by Shaoping Wu Breakdown of academic impact, for papers by Tianlong Liu Breakdown of academic impact, for papers by Su-Min Lim Breakdown of academic impact, for papers by Qamre Alam Breakdown of academic impact, for papers by Songwei Yang